Estimates of over-time trends in incidence and mortality of prostate cancer from 1990 to 2030.

Abstract

BackgroundThis research aims to identify the current and future trends in the incidence and death rate of prostate cancer and to provide the necessary data support for making relevant health decisions.MethodsThis study used the collected data and methodologies to describe the incidence and mortality trends of prostate cancer from 1990 to 2016. Based on the data, this paper projected the future trends in prostate cancer incidence and death rate.ResultsIn 2016, prostate cancer cases [1,435,742; 95% uncertainty interval (UI), 1,293,395–1,618,655] were nearly 2.5-fold the number in 1990 (579,457; 95% UI, 521,564–616,107). Deaths increased by 2.0-fold from 191,687 (95% UI, 168,885–209,254) in 1990 to 380,916 (95% UI, 320,808–412,868) in 2016. The global age-standardized incidence rate (ASIR) increased from 17.75 (95% UI, 18.91–15.95) in 1990 to 22.12 (95% UI, 19.92–24.91) in 2016, changing 24.62%. The global change of age-standardized death rate (ASDR) has declined slightly, but in some regions it shows a trend of growth. By sociodemographic index (SDI) sub-types, prostate cancer will frequently occur in high SDI countries from 1990 to 2030. Simultaneously, the highest mortality will present in low SDI countries.ConclusionsThrough projecting and analyzing incidence and mortality rate of prostate cancer, from 1990 to 2030, by different ages, regions and SDI sub-types, this result may reveal the relationship between prostate cancer and financial development. At the same time, the result also showed a sufficiently heavy burden of prostate cancer, but the burden varies greatly in each region. The burden is a challenge and will require attention for all levels of society. The current study is beneficial to formulate more specific and efficient policies.